Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label six month study to evaluate the safety and efficacy of nitrogen mustard (NM) [chlormethine] 0.04% ointment formulation in patients with stage I or IIA mycosis fungoides (MF) who have completed an initial 12 month treatment with nitrogen mustard 0.02% but without a complete response.

Next Previous
X
Search
Trial Profile

An open label six month study to evaluate the safety and efficacy of nitrogen mustard (NM) [chlormethine] 0.04% ointment formulation in patients with stage I or IIA mycosis fungoides (MF) who have completed an initial 12 month treatment with nitrogen mustard 0.02% but without a complete response.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 16 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Chlormethine (Primary)
  • Indications Mycosis fungoides
  • Focus Therapeutic Use
  • Sponsors Actelion Pharmaceuticals

    • Most Recent Events

    • 10 May 2022 Results of post-hoc analysis published in the American Journal of Clinical Dermatology.
    • 18 Feb 2021 According to a Helsinn Therapeutics media release, it is pleased to note two recent journal publications on the use of mechlorethamine gel 0.016% as a topical treatment of early stage mycosis fungoides-type cutaneous T-cell lymphoma . Bioanalytic testing results indicate lack of systemic absorption of mechlorethamine in plasma samples from the 201 and 202 pivotal study.
    • 06 Dec 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top